Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT01922869
Eligibility Criteria:
Inclusion Criteria:
* Male or Female
* Caucasian of European origin
* Age either between 18-30 years or between 65-77 years
Exclusion Criteria:
* BMI \< 18.5 kg/m2 or BMI \> 30 kg/m2
* Smokers or nicotine users
* High (above 140/90 mmHg ) or low (less than 90/60 mmHg) blood pressure
* Having any existing medical conditions or significant past medical history likely to affect study measurements e.g., type 2 diabetes, cardiovascular, renal, liver or gastrointestinal diseases
* Unsatisfactory biochemical, haematological or urinary assessment, indicating abnormalÍž renal or liver function, full blood profile, impaired glucose handling, deranged lipids or measurements considered to be counter indicative of the study by the clinical advisor
* Taking any prescribed medication that could interact with the enzymes involved in the metabolism of flavonoids
* Taking flavonoid containing supplements or other dietary supplements for one month prior to the study (and duration of the study intervention)
* Known allergies to the intervention foods
* Consume more alcoholic beverages on average than 21 units/wk for men, or 14 units/wk for women (The UK Department of Health recommendations)
* Pregnant, breast feeding, or planning a pregnancy (or having fertility treatment)
* Unable to provide informed consent to participate in the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
77 Years
Study:
NCT01922869
Study Brief:
Protocol Section:
NCT01922869